Edgestream Partners L.P. Takes Position in Molina Healthcare, Inc. (NYSE:MOH)

Edgestream Partners L.P. acquired a new position in shares of Molina Healthcare, Inc. (NYSE:MOH) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 13,114 shares of the company’s stock, valued at approximately $3,899,000.

Several other institutional investors have also recently added to or reduced their stakes in MOH. Renaissance Technologies LLC grew its holdings in shares of Molina Healthcare by 13.3% during the second quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock worth $282,343,000 after buying an additional 111,154 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Molina Healthcare in the 2nd quarter worth approximately $14,546,000. Dimensional Fund Advisors LP grew its stake in Molina Healthcare by 22.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 470,932 shares of the company’s stock worth $140,026,000 after acquiring an additional 84,929 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in Molina Healthcare by 10.1% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,375 shares of the company’s stock valued at $409,000 after acquiring an additional 126 shares during the last quarter. Finally, Plato Investment Management Ltd lifted its stake in shares of Molina Healthcare by 87,050.0% during the 2nd quarter. Plato Investment Management Ltd now owns 1,743 shares of the company’s stock worth $518,000 after purchasing an additional 1,741 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on MOH. Baird R W upgraded Molina Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Jefferies Financial Group dropped their price objective on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research note on Wednesday, July 24th. Cantor Fitzgerald reissued an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a research report on Tuesday, September 10th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. Finally, Stephens reiterated an “equal weight” rating and issued a $320.00 price target on shares of Molina Healthcare in a report on Thursday, July 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $378.00.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $353.05 on Wednesday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. The company has a market cap of $20.69 billion, a PE ratio of 19.16, a P/E/G ratio of 1.20 and a beta of 0.57. The company’s fifty day simple moving average is $331.87 and its 200-day simple moving average is $343.56. Molina Healthcare, Inc. has a 52 week low of $282.96 and a 52 week high of $423.92.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, beating the consensus estimate of $5.73 by $0.13. The company had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The firm’s revenue was up 18.7% compared to the same quarter last year. During the same period last year, the company posted $5.65 earnings per share. As a group, equities research analysts anticipate that Molina Healthcare, Inc. will post 23.5 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.